Overview of precision medicine in solid tumor oncology
This resource is a review of the evolution of precision medicine, cancer care, and the importance of biomarker testing—including guideline recommendations—and key steps along the diagnostic journey.
Tumor biology and precision medicine
This tumor biology resource discusses the precision medicine evolution, which includes molecular profiling, advances in precision medicine science, and how our understanding of tumor biology today may inform patient care tomorrow.
Sample requirements and testing approaches
The sample considerations piece discusses fundamental biomarker testing technologies and their associated sample requirements, where you can learn how to optimize sample collection, including ROSE (rapid on-site evaluation) for tissue sample acquisition, reflex testing, NGS (next-generation sequencing), and liquid biopsy.
Biomarker testing challenges, opportunities, and the MDT
This resource looks at factors that contribute to clinical practice gaps and disparities in care. It also explores how to make testing more equitable, dives into the role of the MDT (multidisciplinary team), and offers real-world solutions to systemic problems.
Considerations for payer coverage and reimbursement
This resource reviews reimbursement considerations, including the 14-day rule, legislation, laboratory benefit managers, and other factors.
Current and future considerations in precision medicine
This resources explores current and future direction in testing, including liquid biopsy, minimal residual disease, and artificial intelligence.